Search research articles
Contact Us
Filters
Showing results (1-10 of 275) with videos related to
Page
of 28
Sort By:
The Lancet. Oncology
|
December 14, 2017
Tumour infiltrating lymphocytes in breast cancer: increasing clinical relevance
Roberto Salgado, Sherene Loi
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 20, 2022
What's in a Name? That Which We Call Immune Cells by Any Other Name Would All Smell as Sweet
Roberto Salgado, Sherene Loi
Eclinicalmedicine
|
November 8, 2021
Quantity of Immune Cells Predict Response to Immunotherapy in Cancer
Roberto Salgado, Thomas Gevaert
Cancer Cell
|
April 11, 2025
AI-driven biomarkers for antibody-drug conjugates
Sherene Loi, Roberto Salgado
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2026
Immunity, age, and luminal breast cancer: understanding the Holy Trinity
Roberto Salgado, Marleen Kok
Public Health Genomics
|
November 20, 2015
Charting the Course for a New Cancer Clinical Research Culture
Sabine Tejpar, Roberto Salgado,
Ebiomedicine
|
September 15, 2023
Artificial intelligence biomarkers for digital oncology: a case study of tumor-infiltrating lymphocytes in melanoma
Roberto Salgado, Khalid AbdulJabbar
Acta Gastroenterologica Latinoamericana
|
June 17, 2015
[Pancreatic intraductal papillary mucinous neoplasm: Case report and review of the literature]
Analia Pasqua, Ricardo Oddi, Toma's Lancelotti, et al.
Current Opinion in Oncology
|
September 4, 2015
Liquid biopsy: will it be the 'magic tool' for monitoring response of solid tumors to anticancer therapies?
Isabelle Gingras, Roberto Salgado, Michail Ignatiadis
Breast Cancer Research and Treatment
|
September 6, 2021
Seeing the forest and the tree: TILs and PD-L1 as immune biomarkers
Peter Savas, Roberto Salgado, Sherene Loi
Page
of 28
Search research articles
Search
Showing results (1-10 of 275) with videos related to
Sort By:
Page
of 28
The Lancet. Oncology
|
December 14, 2017
Tumour infiltrating lymphocytes in breast cancer: increasing clinical relevance
Roberto Salgado, Sherene Loi
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 20, 2022
What's in a Name? That Which We Call Immune Cells by Any Other Name Would All Smell as Sweet
Roberto Salgado, Sherene Loi
Eclinicalmedicine
|
November 8, 2021
Quantity of Immune Cells Predict Response to Immunotherapy in Cancer
Roberto Salgado, Thomas Gevaert
Cancer Cell
|
April 11, 2025
AI-driven biomarkers for antibody-drug conjugates
Sherene Loi, Roberto Salgado
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2026
Immunity, age, and luminal breast cancer: understanding the Holy Trinity
Roberto Salgado, Marleen Kok
Public Health Genomics
|
November 20, 2015
Charting the Course for a New Cancer Clinical Research Culture
Sabine Tejpar, Roberto Salgado,
Ebiomedicine
|
September 15, 2023
Artificial intelligence biomarkers for digital oncology: a case study of tumor-infiltrating lymphocytes in melanoma
Roberto Salgado, Khalid AbdulJabbar
Acta Gastroenterologica Latinoamericana
|
June 17, 2015
[Pancreatic intraductal papillary mucinous neoplasm: Case report and review of the literature]
Analia Pasqua, Ricardo Oddi, Toma's Lancelotti, et al.
Current Opinion in Oncology
|
September 4, 2015
Liquid biopsy: will it be the 'magic tool' for monitoring response of solid tumors to anticancer therapies?
Isabelle Gingras, Roberto Salgado, Michail Ignatiadis
Breast Cancer Research and Treatment
|
September 6, 2021
Seeing the forest and the tree: TILs and PD-L1 as immune biomarkers
Peter Savas, Roberto Salgado, Sherene Loi
Page
of 28